Finally, although our method successfully predicted several kinases, among which CSNK2A1 exhibited a superior inhibitory effect on tumor growth, it is worth considering the utilization of CK2-related drugs for functional verification in future studies on ESCC using additional PDX models, given their ongoing clinical investigation. The gene discussed is CSNK2A1; the disease is neoplasm.